R O T H \\ T E V E T > EXPERIENCEDESIGN

New Era 39thirty Vs 59fifty

SINGAPORE (BUSINESS WIRE) A Bio Pharma Pte Ltd. today announced that Dr. Steven S. Steve joins A Bio from pharmaceutical giant Bristol Myers Squibb Company (BMS), where he held the position of Vice President and General Manager of the Syracuse, New York Manufacturing and Process Development Complex overseeing over 800 employees and a wide range of biological drugs and development candidates including antibody therapeutics.

New Era 39thirty Vs 59fifty

New Era 39thirty Vs 59fifty

"I am delighted to join A Bio with its experienced team of engineers, scientists and GMP trained employees," said Dr. Lee. "As the global development and manufacturing hub for biologics, Singapore is in a unique position today; it is located at the center of the talent pools and markets of Australia, China and India at a time when the biotech industry is expanding worldwide. I envision enormous potential for growth for A Bio as global biologics businesses move to new markets in Asia. A Bio in Singapore is well positioned to capitalize on such growing opportunities."

New Era 39thirty Vs 59fifty

taken the helm at A Bio," said Chu Swee Yeok, CEO of Ny Cap New Era

New Era 39thirty Vs 59fifty

New Era 39thirty Vs 59fifty

New Era 39thirty Vs 59fifty

Dr. Lee was Director of Fermentation and Cell Culture Development at Merck's West Point, Pennsylvania vaccine facility, where he held several positions of increasing responsibility at Merck Research Laboratories and Merck Manufacturing Division since joining in 1990. Dr. Lee received his doctorate in Biochemical Engineering from the Massachusetts Institute of Technology and a Master's in Chemical engineering from the University of Michigan, Ann Arbor.

BioOne Capital, the main investor in A Bio, has been instrumental in developing A Bio as the pioneering biologics player in Singapore. After acquiring Biopharmaceutical Manufacturing Technology Centre (BMTC), A Bio has grown into a strong provider of a full range of process development and GMP manufacturing services. Its customers include large global pharmaceutical companies as well as biotechnology companies.

New Era 39thirty Vs 59fifty

BioOne Capital. "Steve has many years of biologics manufacturing experience. He will bring his invaluable seasoned perspective to A Bio and lead the company into the next important phase of expansion and exciting growth."

"I am very pleased that Steve has New Era Pittsburgh Penguins

New Era 39thirty Vs 59fifty

BioOne Capital, the major shareholder of A Bio, is a leading, dedicated biomedical sciences investment management company in Asia with a worldwide presence. Its investments are focused on promising global biomedical companies where BioOne Capital can play a value adding role in bridging and supporting companies' growth strategies in Asia. Through its extensive networks New Era 39thirty Vs 59fifty with global companies and venture capital corporations, BioOne Capital proactively facilitates partnering and collaborative opportunities to help its portfolio companies grow into sustainable and successful ventures.

Prior to joining BMS in 2002, New Era Edmonton Oilers

A Bio Pharma Pte Ltd Appoints Dr Steven S

New Era 39thirty Vs 59fifty

New Era 39thirty Vs 59fifty

New Era 39thirty Vs 59fifty

Abercrombie And Fitch Blue T Shirt
Hollister Jeans Womens
New Era Minnesota North Stars

Chicago White Sox Cap New Era

Nike Hat Mens

Nike Hat Beanie

Abercrombie And Fitch Black Polo
Hollister Shorts Guys
Jordan Hat White

Ny Yankees Hat Red

Hollister Blue Long Sleeve
Nike Hats Visors

Baltimore Orioles Hats

Nike Cap Winter

Detroit Tigers Hat Orange

Home / New Era 39thirty Vs 59fifty